Clarinex Approval Includes Commitments From Schering On Stability Tests

FDA's approval documents for Schering-Plough's antihistamine Clarinex show that the agency accepted two post-marketing manufacturing commitments from Schering rather than further delay the approval of the antihistamine

More from Archive

More from Pink Sheet